Supplement Articles

Antiangiogenesis Therapy: A New Strategy for Cancer Treatment 7/20/2010

Antiangiogenesis therapy represents one of the most significant advances in clinical oncology. 

Vorinostat and Romidepsin for the Treatment of Cutaneous T-Cell Lymphoma 7/20/2010

Cutaneous T-cell lymphoma is a heterogeneous group of non-Hodgkin's lymphomas that are characterized by T lymphocytes that infiltrate the skin.